Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
Cisplatin is a member of platinum-containing anticancer drugs. Its full name is cis-diamminedichloroplatinum (II) and also called as cisplatinum or platamin etc. The presence of two chlorine atoms in cisplatin can be displaced slowly by water, which in turn displaced by a range of nitrogenous bases present in the DNA. Thus, a complex of cisplatin with nitrogenous bases (especially guanine) causes cross-link of DNA. That means one chlorine atom can be displaced by guanine of one DNA strand while the second chlorine atom is displaced by the guanine of second DNA strand forming DNA cross-link and halting the DNA replication.
The researchers synthesized cis-[Pt(sac)2(NH3)2] as colorless crystals by treating cisplatin with two equivalents of sodium saccharinate in boiling water and similarly they prepared cis-[Pt(tsac)2(NH3)2] using sodium thiosaccharinate.
Researchers took A549 human alveolar type-II cell lines to study the anti-cancer activity of artificial sweeteners Saccharine and Thiosaccharine. They took Methotrexate as a positive control and 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MIT) assay to determine their dose-dependent cytotoxicity. The result revealed that the platinum thiosaccharine complex has higher activity than platinum saccharine complex this is because the Pt-S bond is stronger than the Pt-N bond. However, with respect to the control (Methotrexate) both showed significant anti-cancer activities.
Reference: Journal of Inorganic Biochemistry
Article doi: 10.1016/j.jinorgbio.2014.07.017